3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain, Postoperative
9
Breast Neoplasms
6
Brain Neoplasms
6
Neoplasms
4
Lung Neoplasms
4
Thyroid Neoplasms
3
Agnosia
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Pheochromocytoma
2
Neoplasm Metastasis
2
Liver Neoplasms
2
Dexmedetomidine
2
Colonic Neoplasms
2
Chronic Pain
2
Supratentorial Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Sigmoid Neoplasms
1
Seizures
1
Prostatic Hyperplasia
1
Postoperative Nausea and Vomiting
1
Postoperative Analgesia
1
Pneumoperitoneum
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Obesity
1
Neuroinflammatory Diseases
1
Neurofibromatoses
1
Interventions
Exercise
3
Paclitaxel
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
palbociclib
1
iniparib
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Thioctic Acid
1
Surveys and Questionnaires
1
Sodium Chloride
1
Ropivacaine
1
Radiofrequency Ablation
1
Neoadjuvant Therapy
1
Methotrexate
1
Metformin
1
Mastectomy, Segmental
1
Mastectomy
1
Letrozole
1
Electrochemotherapy
1
Educational Status
1
Drug Delivery Systems
1
Doxorubicin
1
Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Breast Cancer Female
×
Dexmedetomidine
×
Clear all
NCT03063073
2026-02-12
pec's
South Egypt Cancer Institute
Phase 3
Completed
60 enrolled